TScan Therapeutics (TCRX) Other Non-Current Liabilities (2020 - 2025)
TScan Therapeutics' Other Non-Current Liabilities came in at $278,000 for Q3 2025, up 90.4% from $146,000 a year earlier and up 146.0% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
At the end of FY2024, TScan Therapeutics' Other Non-Current Liabilities was $135,000.
- Other Non-Current Liabilities carries a four-year compound annual growth rate of -13.2% (FY2020 to FY2024).
- Going back by year, Other Non-Current Liabilities was $49,000 in FY2022 (-49.5%), $97,000 in FY2021 (-59.2%) and $238,000 in FY2020.
- The Q3 2025 figure represents the highest quarterly Other Non-Current Liabilities in data going back to Q4 2020.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q3 2025 (growth of 90.4%), and the weakest in Q3 2023 (a decline of 87.6%).
- Business Quant data shows TCRX's Other Non-Current Liabilities at $113,000 (Q2 2025), $124,000 (Q1 2025) and $135,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | TScan Therapeutics | 25.99 Mn | -539.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 278,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 124,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | 146,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | 97,000.00 |
| Jun 30, 2022 | 97,000.00 |
| Mar 31, 2022 | 97,000.00 |
| Dec 31, 2021 | 97,000.00 |
| Sep 30, 2021 | 236,000.00 |
| Jun 30, 2021 | 238,000.00 |
| Dec 31, 2020 | 238,000.00 |
API Access
TScan Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();